Skip to main content
. 2019 Sep 17;71(2):581–595. doi: 10.3233/JAD-190228

Fig.1.

Fig.1

Mean placebo-adjusted changes from baseline to Day 15 in CSF levels of Aβ1–40, Aβ1–42, and total Aβ in healthy adults treated with multiple-ascending doses of PF-06751979 in studies B8271001 and B8271004. Aβ, amyloid-β; CSF, cerebrospinal fluid; QD, once daily.